DK1052989T3 - Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion - Google Patents

Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion

Info

Publication number
DK1052989T3
DK1052989T3 DK99901703T DK99901703T DK1052989T3 DK 1052989 T3 DK1052989 T3 DK 1052989T3 DK 99901703 T DK99901703 T DK 99901703T DK 99901703 T DK99901703 T DK 99901703T DK 1052989 T3 DK1052989 T3 DK 1052989T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
trifluoromethoxybenzothiazole
amino
dysfunction
Prior art date
Application number
DK99901703T
Other languages
Danish (da)
English (en)
Inventor
Andrees Bohme
Alain Boireau
Thierry Canton
Assunta Imperato
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1052989T3 publication Critical patent/DK1052989T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99901703T 1998-02-06 1999-02-03 Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion DK1052989T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801402A FR2774592B1 (fr) 1998-02-06 1998-02-06 Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
PCT/FR1999/000230 WO1999039710A1 (fr) 1998-02-06 1999-02-03 Application du 2-amino-6- trifluoromethoxy- benzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet

Publications (1)

Publication Number Publication Date
DK1052989T3 true DK1052989T3 (da) 2003-11-17

Family

ID=9522673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99901703T DK1052989T3 (da) 1998-02-06 1999-02-03 Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion

Country Status (18)

Country Link
US (1) US6245791B1 (de)
EP (1) EP1052989B1 (de)
JP (1) JP5127092B2 (de)
KR (1) KR100574378B1 (de)
AT (1) ATE245982T1 (de)
AU (1) AU761978B2 (de)
CA (1) CA2319686C (de)
DE (1) DE69909970T2 (de)
DK (1) DK1052989T3 (de)
EA (1) EA002676B1 (de)
ES (1) ES2199541T3 (de)
FR (1) FR2774592B1 (de)
IL (2) IL137608A0 (de)
NO (1) NO327819B1 (de)
NZ (1) NZ506124A (de)
PT (1) PT1052989E (de)
WO (1) WO1999039710A1 (de)
ZA (1) ZA99740B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872739B1 (en) 1999-06-04 2005-03-29 Vereniging Voor Christelijk Wetenshappelikjk Onderwijs Use of riluzole for the treatment of multiple sclerosis
US10639298B2 (en) * 2015-03-03 2020-05-05 Biohaven Therapeutics Ltd. Prodrugs of riluzole and their method of use
MD3706739T2 (ro) * 2017-11-12 2025-02-28 Biohaven Therapeutics Ltd Utilizarea promedicamentelor de riluzol pentru tratarea ataxiei
US12364687B2 (en) * 2018-05-27 2025-07-22 Biohaven Therapeutics Ltd. Use of riluzole oral disintegrating tablets for treating diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043070T3 (es) * 1988-12-15 1993-12-16 Rhone Poulenc Sante Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Also Published As

Publication number Publication date
CA2319686A1 (fr) 1999-08-12
NO327819B1 (no) 2009-09-28
ES2199541T3 (es) 2004-02-16
FR2774592A1 (fr) 1999-08-13
IL137608A0 (en) 2001-07-24
KR20010040671A (ko) 2001-05-15
WO1999039710A1 (fr) 1999-08-12
NZ506124A (en) 2003-07-25
AU761978B2 (en) 2003-06-12
JP5127092B2 (ja) 2013-01-23
DE69909970T2 (de) 2004-05-27
PT1052989E (pt) 2003-12-31
NO20003785D0 (no) 2000-07-24
NO20003785L (no) 2000-07-24
DE69909970D1 (de) 2003-09-04
FR2774592B1 (fr) 2000-03-17
ATE245982T1 (de) 2003-08-15
US6245791B1 (en) 2001-06-12
CA2319686C (fr) 2009-06-23
AU2171199A (en) 1999-08-23
ZA99740B (en) 1999-08-02
EP1052989B1 (de) 2003-07-30
IL137608A (en) 2006-09-05
KR100574378B1 (ko) 2006-04-26
EA002676B1 (ru) 2002-08-29
JP2002502819A (ja) 2002-01-29
EP1052989A1 (de) 2000-11-22
EA200000816A1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
DK1066269T3 (da) Trisubstituerede 1,3,5-triazinderivater til behandling af HIV-infektioner
DK1056729T3 (da) N-[(substitueret, femleddet di- eller triaza-diumættet ring)carbonyl]guanidinderivater til behandlingen af iskæmi
BR0109703A (pt) Derivados de piperazina
DE60225341D1 (de) Neue 1,2,4-triazolverbindung
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
BR0216099B1 (pt) "conjunto de desgaste".
WO2005021495A3 (en) Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
DK1066056T3 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, ...
BR9915129A (pt) Antagonistas do receptor de crf e processos relacionados aos mesmos
DK1071422T3 (da) Kombinationer af riluzol og levodopa til behandling af parkinsons sygdom
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
ES2169242T3 (es) 2-amino-benzoxazinonas para el tratamiento de infecciones virales.
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
DE69923995D1 (de) Thiazol-derivate als ppar-gamma-ligande
PT1347984E (pt) Processo para a preparacao de derivados de taxano
NO20003785D0 (no) Anvendelse av 2-amino-6-trifluormetoksy-benzotiazol for prevensjon eller terapi av cerebellum dysfunksjon
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
EP1565448A4 (de) VERFAHREN ZUR HERSTELLUNG VON10H-DIBENZOçB, F] ç1,4]THIAZEPIN-11-ON
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme
DE69930952D1 (de) Gesteuerte freisetzung von antidepressiva
DK1183046T3 (da) Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.
DK1553938T3 (da) Anvendelse af epothilonderivater til behandling af hyperparathyroidisme